<scp>PD</scp>‐L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapyTorben Steiniche, Wei Zhou, Allan Vestergaard Danielsen et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 4
13P Efficacy and biomarker exploration of anlotinib plus penpulimab for extensive-stage small-cell lung cancer who failed previous platinum-based chemotherapy: Results from a phase II perspective trialYi Zhang, Ning Yang, Mengyu Xiao et al.|Immuno-Oncology Technology|2023Cited by 3